✉news ScienceBiology first seen 2 d ago, last 48 min ago, peak #3
Investors turn focus to bioconvergence opportunities
Original: Investing in the age of bioconvergence
Private-market investors are increasingly looking at bioconvergence, the merging of biology with technologies such as AI, engineering and materials science, as a distinct investment theme. The discussion centres on how convergence across biotech, computing and devices is creating new categories of companies and reshaping where venture and growth capital is being deployed.
Why now: Bioconvergence is emerging as a high-growth area at the intersection of biology and technology, attracting investor attention.
bioconvergenceventure capitalbiotechnology
Rank over time, top of the chart is #1. 12 snapshots from 2 d ago to 48 min ago.
Evidence
- Investing in the age of bioconvergence · PEI Private Equity
- Investing in the age of bioconvergence · Buyouts
API: https://socialmediatrends-api.osmike.com/v1/trends/3262210